<DOC>
	<DOC>NCT02455050</DOC>
	<brief_summary>A study to evaluate the tolerability and acceptability of an investigational eye drop formulation in patients with Dry Eye Disease.</brief_summary>
	<brief_title>A Study to Compare a New Eye Drop Formulation With Systane® Gel Drops and Genteal® Lubricant Gel Drops for Moderate to Severe Dry Eye Relief</brief_title>
	<detailed_description />
	<mesh_term>Keratoconjunctivitis Sicca</mesh_term>
	<mesh_term>Dry Eye Syndromes</mesh_term>
	<mesh_term>Ophthalmic Solutions</mesh_term>
	<mesh_term>Tetrahydrozoline</mesh_term>
	<mesh_term>Carboxymethylcellulose Sodium</mesh_term>
	<criteria>Current use of an artificial tear product Visual Acuity of at least 20/40 (while wearing glasses, if necessary). Use of contact lenses in the last 3 months, or anticipated use of contact lenses during the study Cataract surgery, laserassisted in situ keratomileusis (LASIK), photorefractive keratectomy within 6 months Use of RESTASIS® Cyclosporine Ophthalmic Emulsion or any topical cyclosporine within 3 months Diagnosis of glaucoma.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2016</verification_date>
</DOC>